{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:23:20Z","timestamp":1787318600887,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Congenital aniridia is a rare disorder characterized by partial or complete absence of the iris and is usually associated with other ocular and systemic complications. Its lifelong and multisystem nature creates challenges that extend beyond clinical management and require coordinated, multidisciplinary, and equitable healthcare delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A scoping review was conducted using the Arksey and O'Malley framework and Joanna Briggs Institute methodology and reported in accordance with PRISMA-ScR. PubMed, Scopus, and Google Scholar were searched for English-language publications from January 2015 to May 2025 addressing organizational models of care, patient-management strategies, and quality-of-life assessment in congenital aniridia. Included sources were descriptively classified by study design and evidence category. Findings were synthesized using a combined deductive and inductive thematic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fourteen sources met the inclusion criteria and represented different geographical and healthcare settings. The evidence was predominantly observational, retrospective, descriptive, or based on expert and organizational recommendations. Across the reviewed literature, recurrent themes included multidisciplinary coordination, access to specialized expertise, structured referral pathways, registries, telemedicine, lifelong monitoring, genetic counseling, rehabilitation, and patient support. However, direct comparative and longitudinal evaluations of organizational models were lacking. Quality-of-life studies used heterogeneous assessment instruments, limiting direct comparison, although poorer visual function, advanced ocular complications, ocular pain, and broader psychological or systemic burden were generally associated with less favorable patient-reported outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The available evidence supports the principles of lifelong, multidisciplinary, coordinated, and patient-centered care for congenital aniridia. Future health-system development may benefit from strengthened centers of expertise, standardized referral pathways, registry infrastructure, digital consultation, and improved access to specialized services. Prospective multicentre and longitudinal studies are needed to determine the comparative effectiveness of different organizational models and to standardize patient-reported outcome assessment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1890217","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:24:33Z","timestamp":1787315073000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhancing medical care for aniridia through a public health lens: a scoping review of organizational models, patient management, and quality of life assessment"],"prefix":"10.3389","volume":"14","author":[{"given":"Marfuga","family":"Oteuliyeva","sequence":"first","affiliation":[{"name":"Kazakh Scientific Research Institute of Eye Diseases","place":["Almaty, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dastan","family":"Kyrykbayev","sequence":"additional","affiliation":[{"name":"Kazakh Scientific Research Institute of Eye Diseases","place":["Almaty, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnar","family":"Zhurgumbayeva","sequence":"additional","affiliation":[{"name":"Kazakh Scientific Research Institute of Eye Diseases","place":["Almaty, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariga","family":"Smailova","sequence":"additional","affiliation":[{"name":"Kazakh National Medical University named after S.D. Asfendiyarov","place":["Almaty, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Ordabayev","sequence":"additional","affiliation":[{"name":"Kazakh Scientific Research Institute of Eye Diseases","place":["Almaty, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Brusati","sequence":"additional","affiliation":[{"name":"Universit\u00e0 degli Studi di Udine Biblioteca Scientifica e Tecnologica","place":["Udine, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"B1","unstructured":"Tripathy\n              K\n            \n            \n              Salini\n              B\n            \n          \n          Aniridia\n          \n          2025"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.3390\/jcm13216619","article-title":"The triple procedure in patients with congenital aniridia","volume":"13","author":"Wowra","year":"2024","journal-title":"J Clin Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jtos.2021.06.002","article-title":"Dysfunction of the limbal epithelial stem cell niche in aniridia-associated keratopathy","volume":"21","author":"Schl\u00f6tzer-Schrehardt","year":"2021","journal-title":"Ocul Surf."},{"key":"B4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4103\/tjo.TJO-D-23-00140","article-title":"New horizons in aniridia management: clinical insights and therapeutic advances","volume":"13","author":"Gour","year":"2023","journal-title":"Taiwan J Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.survophthal.2021.02.011","article-title":"Congenital aniridia \u2013 a comprehensive review of clinical features and therapeutic approaches","volume":"66","author":"Landsend","year":"2021","journal-title":"Surv Ophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jtos.2019.11.002","article-title":"Early phenotypic features of aniridia-associated keratopathy and association with PAX6 coding mutations","volume":"18","author":"Lagali","year":"2020","journal-title":"Ocul Surf."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1167\/iovs.17-23047","article-title":"Color vision in aniridia","volume":"59","author":"Pedersen","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"733018","DOI":"10.3389\/fped.2021.733018","article-title":"Results from the WAGR syndrome patient registry: characterization of WAGR spectrum and recommendations for care management","volume":"9","author":"Duffy","year":"2021","journal-title":"Front Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00431-025-06101-z","article-title":"Challenges in the clinical management of rare diseases and center-based multidisciplinary approach to creating solutions","volume":"184","author":"Gunes","year":"2025","journal-title":"Eur J Pediatr."},{"key":"B10","unstructured":"Council Recommendation of 8 June 2009 on an action in the field of rare diseases\n          \n          7\n          10\n          Off J Eur Union.\n          \n          2009"},{"key":"B11","unstructured":"European\n              Commission\n            \n            \n              Joint Research\n              Centre\n            \n          \n          European Platform on Rare Disease Registration"},{"key":"B12","unstructured":""},{"key":"B13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/economies11120299","article-title":"Modelling health financing performance in Europe in the context of macroeconomic uncertainties","volume":"11","author":"Dinc\u0103","year":"2023","journal-title":"Economies."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1724402","DOI":"10.3389\/fpubh.2026.1724402","article-title":"Impact of air pollution on life expectancy in Asian developing countries: does renewable energy adoption matter?","volume":"14","author":"Yang","year":"2026","journal-title":"Front Public Health."},{"key":"B15","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1055\/a-2463-3879","article-title":"Standardized assessment of health-related quality of life in patients with congenital aniridia","volume":"242","author":"Hoxha","year":"2025","journal-title":"Klin Monbl Augenheilkd."},{"key":"B16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth."},{"key":"B18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med."},{"key":"B19","unstructured":"Quality of life survey using NEI VFQ-25 in patients with aniridia\n          \n          1576\n          \n            \n              Inokuchi\n              C\n            \n            \n              Oie\n              Y\n            \n            \n              Nishida\n              N\n            \n            \n              Yamada\n              T\n            \n            \n              Shimazaki\n              J\n            \n            \n              Shimmura\n              S\n            \n          \n          Invest Ophthalmol Vis Sci.\n          61\n          2020"},{"key":"B20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/aos.16615","article-title":"Relationship between physical and psychological functioning and health-related quality of life in congenital aniridia","volume":"102","author":"Landsend","year":"2024","journal-title":"Acta Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40123-024-01084-w","article-title":"Systemic diseases in patients with congenital aniridia: a report from the homburg registry for congenital aniridia","volume":"14","author":"Obst","year":"2025","journal-title":"Ophthalmol Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1111\/aos.12923","article-title":"The efficacy and complications of black diaphragm intra-ocular lens implantation in patients with congenital aniridia","volume":"94","author":"Qiu","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00417-016-3292-3","article-title":"Long-term results after artificial iris implantation in patients with aniridia","volume":"254","author":"Rickmann","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"B24","unstructured":"Patient support and advocacy [Internet]"},{"key":"B25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-3-319-19779-1_17","article-title":"European\/International guidelines on aniridia: the patients' point of view","author":"Poli","year":"2015","journal-title":"Aniridia: recent developments in scientific and clinical research"},{"key":"B26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13023-023-02719-0","article-title":"A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance","volume":"18","author":"Hageman","year":"2023","journal-title":"Orphanet J Rare Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"832063","DOI":"10.3389\/fendo.2022.832063","article-title":"Rare disease registries are key to evidence-based personalized medicine: highlighting the European experience","volume":"13","author":"K\u00f6lker","year":"2022","journal-title":"Front Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13023-024-03193-y","article-title":"Scoping review of the recommendations and guidance for improving the quality of rare disease registries","volume":"19","author":"Tarride","year":"2024","journal-title":"Orphanet J Rare Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1186\/s13023-024-03312-9","article-title":"How to customize common data models for rare diseases: an OMOP-based implementation and lessons learned","volume":"58","author":"Ahmadi","year":"2023","journal-title":"J Pediatr Surg."},{"key":"B30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13023-023-02823-1","article-title":"Current state of rare disease registries and databases in Australia: a scoping review","volume":"18","author":"Ruseckaite","year":"2023","journal-title":"Orphanet J Rare Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4103\/0301-4738.100529","article-title":"Social inequalities in blindness and visual impairment: a review of social determinants","volume":"60","author":"Ulldemolins","year":"2012","journal-title":"Indian J Ophthalmol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1001\/jamaophthalmol.2023.0723","article-title":"Association between social determinants of health and examination-based vision loss vs self-reported vision measures","volume":"141","author":"Alfaro Hudak","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/jamaophthalmol.2023.3644","article-title":"Association between health insurance and primary care vision testing among children and adolescents","volume":"141","author":"Killeen","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"100711","DOI":"10.1016\/j.lanwpc.2023.100711","article-title":"Socio-economic costs of rare diseases and the risk of financial hardship: a cross-sectional study","volume":"34","author":"Chung","year":"2023","journal-title":"Lancet Reg Health West Pac."},{"key":"B35","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-022-02299-5","article-title":"The national economic burden of rare disease in the United States in 2019","volume":"17","author":"Yang","year":"2022","journal-title":"Orphanet J Rare Dis."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1890217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:24:35Z","timestamp":1787315075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1890217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":35,"alternative-id":["10.3389\/fpubh.2026.1890217"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1890217","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"article-number":"1890217"}}